111 related articles for article (PubMed ID: 30961466)
1. Drug interaction after ritonavir discontinuation: considerations for antiretroviral therapy changes in renal transplant recipients.
Jimenez HR; Natali KM; Zahran AAR
Int J STD AIDS; 2019 Jun; 30(7):710-714. PubMed ID: 30961466
[TBL] [Abstract][Full Text] [Related]
2. Serum creatinine elevation after switch to dolutegravir in a human immunodeficiency virus-positive kidney transplant recipient.
Lee DH; Malat GE; Bias TE; Harhay MN; Ranganna K; Doyle AM
Transpl Infect Dis; 2016 Aug; 18(4):625-7. PubMed ID: 27159656
[TBL] [Abstract][Full Text] [Related]
3. Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany.
Lopes S; O'Day K; Meyer K; Van Stiphout J; Punekar Y; Radford M; Haas JS
Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):270-278. PubMed ID: 31950545
[TBL] [Abstract][Full Text] [Related]
4. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K;
Lancet; 2019 Jan; 393(10167):143-155. PubMed ID: 30420123
[TBL] [Abstract][Full Text] [Related]
5. Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient.
Erba A; Marzolini C; Rentsch K; Stoeckle M; Battegay M; Mayr M; Weisser M
Virol J; 2023 May; 20(1):89. PubMed ID: 37147711
[TBL] [Abstract][Full Text] [Related]
6. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Venter WDF; Moorhouse M; Sokhela S; Fairlie L; Mashabane N; Masenya M; Serenata C; Akpomiemie G; Qavi A; Chandiwana N; Norris S; Chersich M; Clayden P; Abrams E; Arulappan N; Vos A; McCann K; Simmons B; Hill A
N Engl J Med; 2019 Aug; 381(9):803-815. PubMed ID: 31339677
[TBL] [Abstract][Full Text] [Related]
7. Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants.
Lagoutte-Renosi J; Flammang M; Ducloux D; Bamoulid J; Royer PY; Lepiller Q; Clairet AL; Davani S; Muret P
J Chemother; 2022 May; 34(3):199-202. PubMed ID: 34180378
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine.
Casado JL; Monsalvo M; Vizcarra P; Fontecha M; Serrano-Villar S; Moreno S
HIV Med; 2019 Nov; 20(10):648-656. PubMed ID: 31321875
[TBL] [Abstract][Full Text] [Related]
9. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.
Clotet B; Feinberg J; van Lunzen J; Khuong-Josses MA; Antinori A; Dumitru I; Pokrovskiy V; Fehr J; Ortiz R; Saag M; Harris J; Brennan C; Fujiwara T; Min S;
Lancet; 2014 Jun; 383(9936):2222-31. PubMed ID: 24698485
[TBL] [Abstract][Full Text] [Related]
10. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation.
Azar MM; Malinis MF; Moss J; Formica RN; Villanueva MS
Int J STD AIDS; 2017 Apr; 28(5):447-458. PubMed ID: 27193421
[TBL] [Abstract][Full Text] [Related]
11. Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort.
Ma J; Nance RM; Delaney JAC; Whitney BM; Bamford L; Gravett RM; Moore RD; Napravnik S; Mayer KH; Jacobson JM; Christopoulos K; Burkholder GA; Keruly J; Eron JJ; Martin J; Cachay ER; Saag MS; Crane HM; Kitahata MM
Clin Infect Dis; 2022 Sep; 75(4):715-718. PubMed ID: 35134850
[TBL] [Abstract][Full Text] [Related]
12. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study.
Orrell C; Hagins DP; Belonosova E; Porteiro N; Walmsley S; Falcó V; Man CY; Aylott A; Buchanan AM; Wynne B; Vavro C; Aboud M; Smith KY;
Lancet HIV; 2017 Dec; 4(12):e536-e546. PubMed ID: 28729158
[TBL] [Abstract][Full Text] [Related]
13. Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART.
Palich R; Tubiana R; Abdi B; Mestari F; Guiguet M; Imbert-Bismut F; Katlama C; Bonnefont-Rousselot D; Isnard-Bagnis C
J Antimicrob Chemother; 2018 Jul; 73(7):1935-1939. PubMed ID: 29688533
[TBL] [Abstract][Full Text] [Related]
14. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
[TBL] [Abstract][Full Text] [Related]
15. Human Immunodeficiency Virus in Kidney Transplantation.
Degnan KO; Blumberg EA
Semin Nephrol; 2016 Sep; 36(5):405-416. PubMed ID: 27772625
[TBL] [Abstract][Full Text] [Related]
16. Early neuropsychological adverse events after switching from PI/r to dolutegravir could be related to hyperthyroidism in patients under levothyroxine.
Berger JL; Nguyen Y; Lebrun D; Migault C; Hentzien M; Marty H; Bani-Sadr F
Antivir Ther; 2017; 22(3):271-272. PubMed ID: 27834772
[TBL] [Abstract][Full Text] [Related]
17. Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.
Arribas JR; DeJesus E; van Lunzen J; Zurawski C; Doroana M; Towner W; Lazzarin A; Nelson M; McColl D; Andreatta K; Swamy R; Szwarcberg J; Nguyen T
HIV Clin Trials; 2017 May; 18(3):118-125. PubMed ID: 28555519
[TBL] [Abstract][Full Text] [Related]
18. [Renal transplantation in HIV-infected patients in Spain].
Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
[TBL] [Abstract][Full Text] [Related]
19. Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health.
McComsey GA; Lupo S; Parks D; Poggio MC; De Wet J; Kahl LP; Angelis K; Wynne B; Vandermeulen K; Gartland M; Cupo M; Aboud M;
AIDS; 2018 Feb; 32(4):477-485. PubMed ID: 29239893
[TBL] [Abstract][Full Text] [Related]
20. Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus.
Mertz D; Battegay M; Marzolini C; Mayr M
Am J Kidney Dis; 2009 Jul; 54(1):e1-4. PubMed ID: 19346040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
